Lilly announces agreement with U.S. government to supply 300,000 vials in an effort to fight COVID-19 Read more
Novartis announces collaboration with Molecular Partners to develop two DARPin therapies designed for potential use against COVID-19 Read more
CStone and LegoChem Biosciences Enter Global Licensing Agreement for New Antibody Drug Conjugate Read more
Releviate Therapeutics Inks Exclusive License for Human Monoclonal Antibodies for Chronic Pain Indications Read more
insitro Announces Five-Year Discovery Collaboration with BMS to Discover and Develop Novel Treatments for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Read more
Sanofi and GSK to support COVAX with 200 million doses of adjuvanted, recombinant protein-based COVID-19 vaccine Read more
Apellis and Sobi Enter Collaboration for Global Co-development and Ex-US Commercialization of Systemic Pegcetacoplan in Rare Diseases with Urgent Need for New Treatments Read more
Kala Pharmaceuticals Announces FDA Approval of EYSUVIS for the Short-Term Treatment of the Signs and Symptoms of Dry Eye Disease Read more
Histogen and Amerimmune Enter into a Collaborative Development and Commercialization Agreement for Emricasan in the Treatment of COVID-19 Read more
SFJ Pharmaceuticals partner, Apellis, enters Strategic Collaboration with Sobi to Develop and Commercialize Pegcetacoplan in Hematologic Indications outside the U.S. Read more